Acima Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Acima Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$260K	Hold	493	–	–	0.08%	104
2026 Q1	$277K	Hold	493	–	–	0.09%	106
2025 Q4	$334K	Hold	493	–	–	0.1%	97
2025 Q3	$315K	Hold	493	–	–	0.1%	103
2025 Q2	$264K	Hold	493	–	–	0.09%	107
2025 Q1	$207K	Hold	493	–	–	0.07%	116
2024 Q4	$204K	Hold	493	–	–	0.07%	117
2024 Q3	$249K	Hold	493	–	–	0.08%	114
2024 Q2	$240K	Hold	493	–	–	0.09%	111
2024 Q1	$266K	Hold	493	–	–	0.1%	111
2023 Q4	$274K	Hold	493	–	–	0.11%	110
2023 Q3	$216K	Hold	493	–	–	0.1%	122
2023 Q2	$248K	Hold	493	–	–	0.12%	118
2023 Q1	$247K	Buy	+493	New	+$236K	0.12%	116
2020 Q1	–	Sell	-24	Closed	-$6K	–	275
2019 Q4	$6K	Hold	24	–	–	﹤0.01%	258
2019 Q3	$6K	Hold	24	–	–	﹤0.01%	239
2019 Q2	$7K	Hold	24	–	–	0.01%	214
2019 Q1	$5K	Hold	24	–	–	﹤0.01%	217
2018 Q4	$4K	Buy	+24	New	+$4.92K	﹤0.01%	234

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Acima Private Wealth's IDXX Position: Q2 2026 in Review

Acima Private Wealth held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 493 shares worth $260K. The position accounts for 0.08% of the portfolio, ranked #104.

Acima Private Wealth first reported a position in IDXX in Q4 2018 and has held it in 19 quarters since. The position peaked at $334K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Acima Private Wealth held 493 shares of Idexx Laboratories worth $260K as of Q2 2026.
Acima Private Wealth left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.08% of Acima Private Wealth's portfolio in Q2 2026, its #104 holding.
Acima Private Wealth first reported a position in Idexx Laboratories in Q4 2018 and has held it in 19 quarters since.
Acima Private Wealth's Idexx Laboratories position peaked at $334K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Acima Private Wealth's 13F filing for Q2 2026, filed 6 Jul 2026.